Influence of sex on long-term outcomes after implantation of bare-metal stent a multicenter report from the coronary revascularization demonstrating outcome study-kyoto (CREDO-Kyoto) registry cohort-1

Circulation

Volumn 132, Issue 24, 2015, Pages 2323-2333

  Yamaji, Kyohei ^a   Shiomi, Hiroki ^a   Morimoto, Takeshi ^b   Toyota, Toshiaki ^c   Ono, Koh ^d   Furukawa, Yutaka ^e   Nakagawa, Yoshihisa ^f   Kadota, Kazushige ^g   Ando, Kenji ^h   Shirai, Shinichi ⁱ   Kato, Masayuki ^j   Takatsu, Yoshiki ^k   Doi, Osamu ^l   Kambara, Hirofumi ^a   Suwa, Satoru ^b   Onodera, Tomoya ^c   Watanabe, Hirotoshi ^e   Natsuaki, Masahiro ^a   Kimura, Takeshi ^a,b  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^e TENRI HOSPITAL   (Japan)

^f KURASHIKI CENTRAL HOSPITAL   (Japan)

^g Maizuru Kyosai Hospital   (Japan)

^h HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

ⁱ SHIZUOKA GENERAL HOSPITAL   (Japan)

^j JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^k SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

^l SAISEIKAI FUKUOKA GENERAL HOSPITAL   (Japan)

more..

Author keywords

coronary artery disease; coronary restenosis; sex; stents

Indexed keywords

AGE; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; DEATH; FEMALE; FOLLOW UP; GENERAL PATHOLOGICAL PARAMETERS; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON TARGET LESION REVASCULARIZATION; NONCARDIAC DEATH; PATIENT RISK; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; REVASCULARIZATION; SEX DIFFERENCE; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION; TREATMENT OUTCOME; CLINICAL TRIAL; DEVICES; MIDDLE AGED; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; RESEARCH; RISK FACTOR; SEXUAL DEVELOPMENT; STENT; TIME; TRENDS; VERY ELDERLY;

METAL;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALS; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; RESEARCH REPORT; RISK FACTORS; SEX CHARACTERISTICS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84952630221     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.017168     Document Type: Article

References (36)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489-495. doi: 10.1056/NEJM199408253310801
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994;331:496-501. doi: 10.1056/NEJM199408253310802
3. Doyle B, Rihal CS, OSullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR Jr. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation. 2007;116:2391-2398. doi: 10.1161/CIRCULATIONAHA.107.707331
4. Holmes DR Jr, Williams DO. Catheter-based treatment of coronary artery disease: past, present, and future. Circ Cardiovasc Interv. 2008;1:60-73. doi: 10.1161/CIRCINTERVENTIONS.108.783134
5. Yamaji K, Kimura T, Morimoto T, Nakagawa Y, Inoue K, Soga Y, Arita T, Shirai S, Ando K, Kondo K, Sakai K, Goya M, Iwabuchi M, Yokoi H, Nosaka H, Nobuyoshi M. Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation. Circ Cardiovasc Interv. 2010;3:468-475. doi: 10.1161/CIRCINTERVENTIONS.110.958249
6. Hsieh IC, Hsieh MJ, Chang SH, Wang CY, Lee CH, Lin FC, Chen CC. Clinical and angiographic outcomes after intracoronary bare-metal stenting. PLoS One. 2014;9:e94319. doi: 10.1371/journal.pone.0094319
7. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnr F, Falotico R; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780. doi: 10.1056/NEJMoa012843
8. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, OShaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323. doi: 10.1056/NEJMoa035071
9. Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, DAscenzo F, Kimura T, Briguori C, Sabat M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-Analysis. Lancet. 2012;379:1393-1402. doi: 10.1016/S0140-6736(12)60324-9
10. Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA, Meier B, Jni P, Windecker S. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. JACC Cardiovasc Interv. 2013;6:777-789. doi: 10.1016/j.jcin.2013.04.011
11. Shiomi H, Kozuma K, Morimoto T, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Abe M, Suwa S, Muramatsu T, Kobayashi M, Dai K, Nakao K, Uematsu M, Tarutani Y, Fujii K, Simonton CA, Kimura T; RESET Investigators. Long-term clinical outcomes after everolimus-And sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial. Circ Cardiovasc Interv. 2014;7:343-354. doi: 10.1161/CIRCINTERVENTIONS.113.001322
12. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371:899-907. doi: 10.1016/S0140-6736(08)60415-8
13. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hbert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897-910. doi: 10.1016/S0140-6736(09)60325-1
14. Funakoshi S, Furukawa Y, Ehara N, Morimoto T, Kaji S, Yamamuro A, Kinoshita M, Kitai T, Kim K, Tani T, Kobori A, Nasu M, Okada Y, Kita T, Kimura T; CREDO-Kyoto Investigators. Clinical characteristics and outcomes of Japanese women undergoing coronary revascularization therapy. Circ J. 2011;75:1358-1367
15. Mehilli J, Kastrati A, Bollwein H, Dibra A, Schhlen H, Dirschinger J, Schmig A. Gender and restenosis after coronary artery stenting. Eur Heart J. 2003;24:1523-1530
16. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, Taniguchi R, Doi T, Nishiyama K, Ozasa N, Saito N, Hoshino K, Mitsuoka H, Abe M, Toma M, Tamura T, Haruna Y, Imai Y, Teramukai S, Fukushima M, Kita T. Long-term outcomes of coronary-Artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation. 2008;118(14 suppl):S199-S209. doi: 10.1161/CIRCULATIONAHA.107.735902
17. Mauri L, Hsieh WH, Massaro JM, Ho KK, DAgostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-1029. doi: 10.1056/NEJMoa067731
18. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schnberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46:575-581. doi: 10.1016/j.jacc.2004.12.082
19. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706
20. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol. 1983;1:710-719
21. Inoue K, Abe K, Ando K, Shirai S, Nishiyama K, Nakanishi M, Yamada T, Sakai K, Nakagawa Y, Hamasaki N, Kimura T, Nobuyoshi M, Miyamoto TA. Pathological analyses of long-term intracoronary Palmaz-Schatz stenting; Is its efficacy permanent? Cardiovasc Pathol. 2004;13:109-115. doi: 10.1016/S1054-8807(03)00132-7
22. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57:1314-1322. doi: 10.1016/j.jacc.2011.01.011
23. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Late adverse events after implantation of sirolimuseluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2. Circ Cardiovasc Interv. 2014;7:168-179. doi: 10.1161/CIRCINTERVENTIONS.113.000987
24. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, Meier B, Hess OM. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol. 2005;46:231-236. doi: 10.1016/j.jacc.2005.01.062
25. Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW, Park CG, Seo HS, Oh DJ. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent. JACC Cardiovasc Interv. 2008;1:65-71. doi: 10.1016/j.jcin.2007.11.002
26. Brugaletta S, Heo JH, Garcia-Garcia HM, Farooq V, van Geuns RJ, de Bruyne B, Dudek D, Smits PC, Koolen J, McClean D, Dorange C, Veldhof S, Rapoza R, Onuma Y, Bruining N, Ormiston JA, Serruys PW. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Eur Heart J. 2012;33:1325-1333. doi: 10.1093/eurheartj/ehr466
27. Toyota T, Furukawa Y, Ehara N, Funakoshi S, Morimoto T, Kaji S, Nakagawa Y, Kadota K, Iwabuchi M, Shiomi H, Yamamuro A, Kinoshita M, Kitai T, Kim K, Tani T, Kobori A, Kita T, Sakata R, Kimura T; Credo-Kyoto Investigators. Sex-based differences in clinical practice and outcomes for Japanese patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J. 2013;77:1508-1517
28. Lempereur M, Magne J, Cornelis K, Hanet C, Taeymans Y, Vrolix M, Legrand V. Impact of gender difference in hospital outcomes following percutaneous coronary intervention. Results of the Belgian Working Group on Interventional Cardiology (BWGIC) registry. EuroIntervention. 2014;1-8
29. Stefanini GG, Kalesan B, Pilgrim T, Rber L, Onuma Y, Silber S, Serruys PW, Meier B, Jni P, Windecker S. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drugeluting stents. JACC Cardiovasc Interv. 2012;5:301-310. doi: 10.1016/j.jcin.2011.11.011
30. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 1983;50:127-134
31. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1057
32. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998;97:2110-2116
33. Han SH, Bae JH, Holmes DR Jr, Lennon RJ, Eeckhout E, Barsness GW, Rihal CS, Lerman A. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J. 2008;29:1359-1369. doi: 10.1093/eurheartj/ehn142
34. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497
35. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, Saito Y, Kawabata K, Sano K, Kobayashi T, Yano T, Nakamura K, Kugiyama K. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009;53:323-330. doi: 10.1016/j.jacc.2008.08.074
36. Lavi S, Bae JH, Rihal CS, Prasad A, Barsness GW, Lennon RJ, Holmes DR Jr, Lerman A. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart. 2009;95:1525-1530. doi: 10.1136/hrt.2009.166017